{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:17:29Z","timestamp":1791001049195,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","mayoclinicproceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.mayocp.2017.05.026","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T12:00:16Z","timestamp":1501588816000},"page":"1234-1247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["My Treatment Approach to Gout"],"prefix":"10.1016","volume":"92","author":[{"given":"Fawad","family":"Aslam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Clement","family":"Michet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mayocp.2017.05.026_bib1","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mayocp.2017.05.026_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar3199","article-title":"Epidemiology of gout","volume":"12","author":"Roddy","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.mayocp.2017.05.026_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2017.05.026_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","article-title":"Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008","volume":"125","author":"Zhu","year":"2012","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.mayocp.2017.05.026_bib5","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","article-title":"Gout: why is this curable\u00a0disease so seldom cured?","volume":"71","author":"Doherty","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2017.05.026_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2017.05.026_bib7","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/ard.2007.070755","article-title":"Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations","volume":"66","author":"Roddy","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"10.1016\/j.mayocp.2017.05.026_bib8","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1001\/jama.2014.14484","article-title":"Eligibility for and prescription of urate-lowering treatment in patients\u00a0with incident gout in England","volume":"312","author":"Kuo","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.mayocp.2017.05.026_bib9","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout, part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.mayocp.2017.05.026_bib10","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout, part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.mayocp.2017.05.026_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2017.05.026_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s40265-016-0550-y","article-title":"Lesinurad: first global approval","volume":"76","author":"Hoy","year":"2016","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.mayocp.2017.05.026_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s100670050005","article-title":"How is gout managed in primary care? a review of current practice and proposed guidelines","volume":"19","author":"Pal","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.mayocp.2017.05.026_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/18743129014090100021","article-title":"Diagnosis and treatment of acute gout at a university hospital emergency department","volume":"9","author":"Schlesinger","year":"2015","journal-title":"Open Rheumatol J"},{"issue":"13","key":"10.1016\/j.mayocp.2017.05.026_bib15","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archinternmed.2010.196","article-title":"A\u00a0diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis","volume":"170","author":"Janssens","year":"2010","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2017.05.026_bib16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/rheumatology\/keu378","article-title":"The validation of a diagnostic rule for gout without joint fluid analysis: a prospective study","volume":"54","author":"Kienhorst","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.mayocp.2017.05.026_bib17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2017.05.026_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.mayocp.2017.05.026_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.56.11.696a","article-title":"Serum uric acid in acute gout","volume":"56","author":"Logan","year":"1997","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2017.05.026_bib20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3899\/jrheum.080938","article-title":"Serum urate during acute gout","volume":"36","author":"Schlesinger","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"5851","key":"10.1016\/j.mayocp.2017.05.026_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/bmj.1.5851.449","article-title":"Effect of oestrogen therapy on plasma and urinary levels of uric acid","volume":"1","author":"Nicholls","year":"1973","journal-title":"Br Med J"},{"issue":"9179","key":"10.1016\/j.mayocp.2017.05.026_bib22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(99)92381-4","article-title":"Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia","volume":"354","author":"Sumino","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2017.05.026_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12891-017-1465-9","article-title":"Sex differences in gout characteristics: tailoring care for women and men","volume":"18","author":"Harrold","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"10.1016\/j.mayocp.2017.05.026_bib25","first-page":"2186","article-title":"Female gout: clinical and laboratory features","volume":"32","author":"De Souza","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.mayocp.2017.05.026_bib26","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201607050","article-title":"Gout","volume":"165","author":"Neogi","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mayocp.2017.05.026_bib27","first-page":"1569","article-title":"Clinical gout","volume":"Vol. 2","author":"Edwards","year":"2015"},{"issue":"4","key":"10.1016\/j.mayocp.2017.05.026_bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2214\/ajr.134.4.781","article-title":"A\u00a0radiologic reevaluation of gout: a study of 2,000 patients","volume":"134","author":"Bloch","year":"1980","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.mayocp.2017.05.026_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.rdc.2014.01.004","article-title":"Imaging in the crystal arthropathies","volume":"40","author":"McQueen","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.mayocp.2017.05.026_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1754-9485.12356","article-title":"Gouty arthropathy: review of clinico-pathologic and imaging features","volume":"60","author":"Parathithasan","year":"2016","journal-title":"J\u00a0Med Imaging Radiat Oncol"},{"issue":"5","key":"10.1016\/j.mayocp.2017.05.026_bib31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2012-202301","article-title":"A\u00a0systematic review of ultrasonography in gout and asymptomatic hyperuricaemia","volume":"72","author":"Chowalloor","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2017.05.026_bib32","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1136\/annrheumdis-2014-205431","article-title":"Imaging modalities for the classification of gout: systematic literature review and meta-analysis","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2017.05.026_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/art.39959","article-title":"Performance of ultrasound in the diagnosis of gout in a multicenter study: comparison with monosodium urate monohydrate crystal analysis as the gold standard","volume":"69","author":"Ogdie","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.mayocp.2017.05.026_bib34","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jbspin.2013.12.001","article-title":"Arthritis of the first metatarsophalangeal joint is not always gout: a prospective cohort study in primary care patients","volume":"81","author":"Kienhorst","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.mayocp.2017.05.026_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jbspin.2014.03.011","article-title":"Ultrasound in gout: a useful tool for following urate-lowering therapy","volume":"82","author":"Ottaviani","year":"2015","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.mayocp.2017.05.026_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.amjmed.2016.08.034","article-title":"Use of ultrasound by internists to improve diagnostic small joint aspiration","volume":"130","author":"Greenlund","year":"2017","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2017.05.026_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/RHU.0000000000000228","article-title":"Ultrasound-guided dry-needle synovial tissue aspiration for diagnostic microscopy in gout patients presenting without synovial effusion or clinically detectable tophi","volume":"21","author":"Slot","year":"2015","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.mayocp.2017.05.026_bib38","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/acr.20527","article-title":"Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition: concordance between readers","volume":"63","author":"Howard","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.mayocp.2017.05.026_bib39","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/acr.23082","article-title":"Ultrasound features of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: comparison with normouricaemic individuals","volume":"69","author":"Stewart","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.mayocp.2017.05.026_bib40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13075-015-0701-7","article-title":"A\u00a0prospective evaluation of ultrasound as a diagnostic tool in acute microcrystalline arthritis","volume":"17","author":"Zufferey","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.mayocp.2017.05.026_bib41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00256-015-2324-0","article-title":"Survey of current trends in postgraduate musculoskeletal ultrasound education in the United States","volume":"45","author":"Berko","year":"2016","journal-title":"Skeletal Radiol"},{"issue":"5","key":"10.1016\/j.mayocp.2017.05.026_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-0035-1569253","article-title":"Dual-energy CT: basic principles, technical approaches, and applications in musculoskeletal imaging (part 1)","volume":"19","author":"Omoumi","year":"2015","journal-title":"Semin Musculoskelet Radiol"},{"issue":"12","key":"10.1016\/j.mayocp.2017.05.026_bib43","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.acra.2015.08.010","article-title":"Comparison between dual-energy computed tomography and ultrasound in the diagnosis of gout of various joints","volume":"22","author":"Zhu","year":"2015","journal-title":"Acad Radiol"},{"issue":"6","key":"10.1016\/j.mayocp.2017.05.026_bib44","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/annrheumdis-2013-205095","article-title":"Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study","volume":"74","author":"Bongartz","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2017.05.026_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/rheumatology\/ket341","article-title":"Dual-energy computed tomography compared with ultrasound in the diagnosis of gout","volume":"53","author":"Gruber","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.mayocp.2017.05.026_bib46","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00296-014-2979-1","article-title":"Systemic staging for urate crystal deposits with dual-energy CT and ultrasound in patients with suspected gout","volume":"34","author":"Huppertz","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.mayocp.2017.05.026_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12891-016-0943-9","article-title":"Dual-energy computed tomography has limited sensitivity for non-tophaceous gout: a comparison study with tophaceous gout","volume":"17","author":"Baer","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"10.1016\/j.mayocp.2017.05.026_bib48","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1148\/radiol.11102485","article-title":"Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation","volume":"261","author":"Glazebrook","year":"2011","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.mayocp.2017.05.026_bib49","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.semarthrit.2013.11.002","article-title":"Gout tophus detection: a comparison of dual-energy CT (DECT) and histology","volume":"43","author":"Melzer","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.mayocp.2017.05.026_bib50","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.semarthrit.2015.09.008","article-title":"Imaging as a potential outcome measure in gout studies: a systematic literature review","volume":"45","author":"Durcan","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.mayocp.2017.05.026_bib51","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/art.39717","article-title":"Polyarthritis as a rare presentation of hydroxyapatite deposition disease","volume":"68","author":"Aslam","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.mayocp.2017.05.026_bib52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/M16-0570","article-title":"Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2017.05.026_bib53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7326\/M16-2401","article-title":"To treat or not to treat (to target) in gout","volume":"166","author":"Neogi","year":"2017","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.mayocp.2017.05.026_bib54","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/15257770.2011.596496","article-title":"Japanese guideline for the management of hyperuricemia and gout: second edition","volume":"30","author":"Yamanaka","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.mayocp.2017.05.026_bib55","first-page":"1575","article-title":"Clinical gout","volume":"Vol. 2","author":"Terkeltaub","year":"2015"},{"issue":"9627","key":"10.1016\/j.mayocp.2017.05.026_bib56","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0140-6736(08)60799-0","article-title":"Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial","volume":"371","author":"Janssens","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mayocp.2017.05.026_bib57","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.annemergmed.2006.11.014","article-title":"Comparison of oral prednisolone\/paracetamol and oral indomethacin\/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial","volume":"49","author":"Man","year":"2007","journal-title":"Ann Emerg Med"},{"issue":"7","key":"10.1016\/j.mayocp.2017.05.026_bib58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/M14-2070","article-title":"Oral prednisolone in the treatment of acute gout: a pragmatic, multicenter, double-blind, randomized trial","volume":"164","author":"Rainer","year":"2016","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2017.05.026_bib59","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mayocp.2017.05.026_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","article-title":"Prevalence of contraindications and prescription of pharmacologic therapies for gout","volume":"124","author":"Keenan","year":"2011","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2017.05.026_bib61","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/art.20102","article-title":"Quality of care indicators for gout management","volume":"50","author":"Mikuls","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.mayocp.2017.05.026_bib62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: the dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"issue":"21","key":"10.1016\/j.mayocp.2017.05.026_bib63","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2017.05.026_bib64","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","article-title":"Colchicine update: 2008","volume":"38","author":"Terkeltaub","year":"2009","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.mayocp.2017.05.026_bib65","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.30389","article-title":"Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mayocp.2017.05.026_bib66","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","article-title":"Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study","volume":"72","author":"Rees","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mayocp.2017.05.026_bib67","series-title":"Rheumatology Secrets","first-page":"645","article-title":"Hypouricemic agents and colchicine","author":"Finger","year":"2015"},{"key":"10.1016\/j.mayocp.2017.05.026_bib68","unstructured":"UpToDate. Colchicine. Vol 2017."},{"issue":"5","key":"10.1016\/j.mayocp.2017.05.026_bib69","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/art.22232","article-title":"Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study","volume":"55","author":"Perez-Ruiz","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.mayocp.2017.05.026_bib70","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/RHU.0000000000000235","article-title":"Does starting allopurinol prolong acute treated gout? a randomized clinical trial","volume":"21","author":"Hill","year":"2015","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.mayocp.2017.05.026_bib71","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.amjmed.2012.05.025","article-title":"Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial","volume":"125","author":"Taylor","year":"2012","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.mayocp.2017.05.026_bib72","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/aje\/kwp033","article-title":"Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study","volume":"169","author":"Chen","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.mayocp.2017.05.026_bib73","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/aje\/kwm127","article-title":"Plasma urate and risk of Parkinson's disease","volume":"166","author":"Weisskopf","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.mayocp.2017.05.026_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3949\/ccjm.78c.02001","article-title":"Gout and chronic kidney disease","volume":"78","author":"Mandell","year":"2011","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2017.05.026_bib75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2169\/internalmedicine.53.0698","article-title":"Successful treatment of refractory gout using combined therapy consisting of febuxostat and allopurinol in a patient with chronic renal failure","volume":"53","author":"Maekawa","year":"2014","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.mayocp.2017.05.026_bib76","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.30119","article-title":"Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment","volume":"63","author":"Stamp","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mayocp.2017.05.026_bib77","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/annrheumdis-2016-210356","article-title":"Response: renal dosing of allopurinol results in suboptimal gout care by T Neogi et\u00a0al","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2017.05.026_bib78","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/tpj.2015.101","article-title":"ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout","volume":"17","author":"Roberts","year":"2017","journal-title":"Pharmacogenomics J"},{"issue":"10","key":"10.1016\/j.mayocp.2017.05.026_bib79","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s40264-013-0084-0","article-title":"Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012","volume":"36","author":"Ramasamy","year":"2013","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.mayocp.2017.05.026_bib80","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/106002809302700317","article-title":"Allopurinol hypersensitivity syndrome: a review","volume":"27","author":"Arellano","year":"1993","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.mayocp.2017.05.026_bib81","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/art.39654","article-title":"Impact of febuxostat on renal function in gout patients with moderate-to-severe renal impairment","volume":"68","author":"Saag","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.mayocp.2017.05.026_bib82","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1002\/art.39769","article-title":"Febuxostat for patients with gout and severe chronic kidney disease: which is the appropriate dosage? comment on the article by Saag et\u00a0al","volume":"68","author":"Quilis","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.mayocp.2017.05.026_bib83","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jbspin.2015.07.011","article-title":"Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol: a retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment","volume":"83","author":"Bardin","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"9","key":"10.1016\/j.mayocp.2017.05.026_bib84","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3899\/jrheum.110092","article-title":"Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions","volume":"38","author":"Chohan","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.mayocp.2017.05.026_bib85","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40265-015-0360-7","article-title":"Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout","volume":"75","author":"Frampton","year":"2015","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.mayocp.2017.05.026_bib87","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/art.10792","article-title":"Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mayocp.2017.05.026_bib88","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1759720X16646703","article-title":"Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications","volume":"8","author":"Sattui","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2017.05.026_bib89","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","article-title":"Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials","volume":"306","author":"Sundy","year":"2011","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.mayocp.2017.05.026_bib90","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1136\/annrheumdis-2012-201795","article-title":"Long-term safety of pegloticase in chronic gout refractory to conventional treatment","volume":"72","author":"Becker","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mayocp.2017.05.026_bib91","doi-asserted-by":"crossref","first-page":"d8190","DOI":"10.1136\/bmj.d8190","article-title":"Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study","volume":"344","author":"Choi","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.mayocp.2017.05.026_bib92","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.phrs.2015.09.012","article-title":"Plasma uric acid concentrations are reduced by fenofibrate: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"102","author":"Derosa","year":"2015","journal-title":"Pharmacol Res"},{"issue":"9","key":"10.1016\/j.mayocp.2017.05.026_bib93","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s40265-016-0591-2","article-title":"Impact of statin therapy on plasma uric acid concentrations: a systematic review and meta-analysis","volume":"76","author":"Derosa","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.mayocp.2017.05.026_bib94","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12906-016-1067-3","article-title":"A\u00a0cross-sectional internet-based patient survey of the management strategies for gout","volume":"16","author":"Singh","year":"2016","journal-title":"BMC Complement Altern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2017.05.026_bib95","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/acr.22785","article-title":"Target serum urate: do gout patients know their goal?","volume":"68","author":"Coburn","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.mayocp.2017.05.026_bib96","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/acr.22336","article-title":"Medication adherence in gout: a systematic review","volume":"66","author":"De Vera","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9417","key":"10.1016\/j.mayocp.2017.05.026_bib97","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","article-title":"Alcohol intake and risk of incident gout in men: a prospective study","volume":"363","author":"Choi","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2017.05.026_bib98","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.23245","article-title":"Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey","volume":"59","author":"Choi","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mayocp.2017.05.026_bib99","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/art.22712","article-title":"Coffee consumption and risk of incident gout in men: a prospective study","volume":"56","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.mayocp.2017.05.026_bib100","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/art.22762","article-title":"Coffee, tea, and caffeine consumption and serum uric acid level: the third National Health and Nutrition Examination Survey","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.mayocp.2017.05.026_bib101","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men","volume":"350","author":"Choi","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.mayocp.2017.05.026_bib102","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1002\/art.34677","article-title":"Cherry consumption and decreased risk of recurrent gout attacks","volume":"64","author":"Zhang","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mayocp.2017.05.026_bib103","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/imj.12661","article-title":"Comprehensive dietary education in treated gout patients does not further improve serum urate","volume":"45","author":"Holland","year":"2015","journal-title":"Intern Med J"},{"issue":"5","key":"10.1016\/j.mayocp.2017.05.026_bib104","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1053\/j.ajkd.2008.07.035","article-title":"Management of hyperuricemia and gout in CKD","volume":"52","author":"Gaffo","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2017.05.026_bib105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2169\/internalmedicine.48.1817","article-title":"Sevelamer decreases serum uric acid concentration through adsorption of uric acid in maintenance hemodialysis patients","volume":"48","author":"Ohno","year":"2009","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.mayocp.2017.05.026_bib106","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar3272","article-title":"Contemporary epidemiology of gout in the UK general population","volume":"13","author":"Cea Soriano","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.mayocp.2017.05.026_bib107","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11926-012-0235-9","article-title":"Gout and organ transplantation","volume":"14","author":"Stamp","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.mayocp.2017.05.026_bib108","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7547\/14-128","article-title":"Surgical management of gout in the foot and ankle: a systematic review","volume":"106","author":"Poratt","year":"2016","journal-title":"J\u00a0Am Podiatr Med Assoc"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619617304081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619617304081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T20:58:26Z","timestamp":1535576306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619617304081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":106,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0025619617304081"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.05.026","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"My Treatment Approach to Gout","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}